Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 1,050,000 shares, a decrease of 15.3% from the March 31st total of 1,240,000 shares. Based on an average daily volume of 341,300 shares, […]